Page last updated: 2024-08-26

3,4-dihydroxyphenylglycol and neuropeptide y

3,4-dihydroxyphenylglycol has been researched along with neuropeptide y in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's4 (57.14)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bratholm, P; Christensen, NJ; Eldrup, E; Hetland, ML1
Hunter, LW; Rorie, DK; Tyce, GM1
Hunter, LW; Lunn, JJ; Rorie, DK1
Haass, M; Hock, M; Richardt, G; Schömig, A1
Hunter, LW; Rorie, DK; Tyce, GM; Yaksh, TL1
Chahine, R; de Champlain, J; Lamontagne, D; Nadeau, R; Yamaguchi, N1
Esler, M; Hastings, JA; Lambert, E; Lambert, G; Morris, MJ1

Other Studies

7 other study(ies) available for 3,4-dihydroxyphenylglycol and neuropeptide y

ArticleYear
The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
    Scandinavian journal of clinical and laboratory investigation, 1991, Volume: 51, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Catecholamines; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropeptide Y; Norepinephrine; Supination; Sympathetic Nervous System

1991
Neuropeptide Y and 3,4-dihydroxyphenylglycol effluxes from artery are oxygen sensitive.
    The American journal of physiology, 1991, Volume: 261, Issue:5 Pt 2

    Topics: Animals; Dogs; Electric Stimulation; Female; In Vitro Techniques; Kinetics; Male; Methoxyhydroxyphenylglycol; Muscle, Smooth, Vascular; Neuropeptide Y; Norepinephrine; Oxygen; Partial Pressure; Perfusion; Pulmonary Artery

1991
Halothane decreases the release of neuropeptide Y and 3,4-dihydroxyphenylglycol from superfused segments of dog pulmonary artery.
    Anesthesiology, 1990, Volume: 73, Issue:4

    Topics: Animals; Depression, Chemical; Dogs; Electric Stimulation; Female; Halothane; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Neuropeptide Y; Norepinephrine; Pulmonary Artery; Sympathetic Nervous System

1990
Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart.
    Naunyn-Schmiedeberg's archives of pharmacology, 1989, Volume: 340, Issue:5

    Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Calcium; Chromatography, High Pressure Liquid; Electric Stimulation; Exocytosis; Ganglia, Sympathetic; Guinea Pigs; Hypoxia; Methoxyhydroxyphenylglycol; Myocardium; Neuropeptide Y; Norepinephrine; Radioimmunoassay; Tyramine; Veratridine

1989
Concurrent separation of catecholamines, dihydroxyphenylglycol, vasoactive intestinal peptide, and neuropeptide Y in superfusate and tissue extract.
    Analytical biochemistry, 1988, Volume: 173, Issue:2

    Topics: Animals; Catecholamines; Chromatography, High Pressure Liquid; Dogs; Female; Glycols; Male; Methoxyhydroxyphenylglycol; Neuropeptide Y; Pulmonary Artery; Radioimmunoassay; Rats; Rats, Inbred Strains; Vasoactive Intestinal Peptide

1988
Norepinephrine and dihydroxyphenylglycol effluxes from sympathetic nerve endings during hypoxia and reoxygenation in the isolated rat heart.
    Canadian journal of physiology and pharmacology, 1994, Volume: 72, Issue:6

    Topics: Animals; Calcium; Coronary Circulation; Glucose; Heart; Hypoxia; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Nerve Endings; Neuropeptide Y; Norepinephrine; Oxygen Consumption; Rats; Rats, Wistar; Sympathetic Nervous System

1994
NPY and NPY Y1 receptor effects on noradrenaline overflow from the rat brain in vitro.
    Regulatory peptides, 2004, Aug-15, Volume: 120, Issue:1-3

    Topics: Animals; Appetite; Brain; Chromatography, High Pressure Liquid; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Neuropeptide Y; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Time Factors

2004